Your shopping cart is empty!
Clinical and Laboratory Standards Institute, 09/20/2002
Publisher: CLSI
File Format: PDF
$120.00$240.61
Published:20/09/2002
Pages:56
CLSI EP09-A2 addresses procedures for determining the bias between two clinical methods or devices, and for the design of a method comparison experiment using split patient samples and data analysis.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guidleine for use in satisfying a regulatory requirement.
Point-of-Care Connectivity; Approved Standard, POCT01A2E
$90.00 $180.00
Body Fluid Analysis for Cellular Composition; Approved Guideline, H56AE
Molecular Diagnostic Methods for Genetic Diseases; Approved Guideline, MM01-A2
$134.00 $268.44
Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions; Approved Guideline, C24A3E
$121.00 $242.75
